Table 1.

Demographic Information of Immunocompromised Patients (n = 887) by Vaccination Status

Total ≥ 3 mRNA Vaccines ≤2 mRNA Vaccines
n(%)n(%)n(%)p-Value
Total887(100.0)556(62.7)331(37.3)--
Race*
 White227(25.6)170(74.9)57(25.1)0.1292
 Black or African American591(66.7)343(58.0)248(42.0)
 Hispanic43(4.8)28(65.1)15(35.9)
 Asian21(2.4)13(61.9)8(38.1)
 American Indian or Alaskan Native4(0.5)4(100.0)0(0.0)
 Other/Unknown7(0.8)3(42.9)4(57.1)
Age, y
 20–2922(2.5)4(18.2)18(81.9)0.1124
 30–3948(5.4)14(29.2)34(70.8)
 40–4989(10.0)42(47.2)47(52.8)
 50–59184(20.7)112(60.9)72(39.1)
 60–69258(29.1)172(66.7)86(33.3)
 70–79203(22.9)145(71.4)58(28.6)
 80+83(9.4)67(80.7)16(19.3)
Sex
 Female391(44.1)236(60.4)155(39.6)0.1738
 Male496(55.9)320(64.5)176(35.5)
Diagnosis
 Hematologic cancers12(1.4)9(75.0)3(25.0)0.2428
 Solid tumor cancers§555(62.6)371(66.8)184(33.2)
 Autoimmune disorders30(3.4)19(63.3)11(36.7)
 Solid organ transplant recipients46(5.2)29(63.0)17(37.0)
 HIV/AIDS211(23.8)122(57.8)89(42.2)
 Patients on Dialysis94(10.6)43(45.7)51(54.3)
  • Notes. *Some patients identified with more than one race, so the values in this category add up to greater than the total sample size.

  • Patients may have had more than one diagnosis, so the values in this category add up to greater than the total sample size.

  • Diagnoses included in this category: diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML).

  • § Diagnoses included in this category: breast cancer, lung cancer, prostate cancer, colorectal cancer, melanoma, bladder cancer, head and neck cancer.

  • Diagnoses included in this category: autoimmune hepatitis, psoriatic arthritis, spondyloarthritis, ankylosing spondylitis, rheumatoid arthritis, primary biliary cholangitis, dermatomyositis, systemic lupus erythematosus, primary Sjögren’s syndrome, systemic sclerosis.

  • Transplants included in this category: kidney, liver, heart/lung, pancreas.